Increased Cerebrospinal Fluid S100B and NSE Reflect Neuronal and Glial Damage in Parkinson’s Disease
Introduction: The diagnosis of Parkinson’s disease (PD) mainly relies on clinical manifestation, but may be difficult to make in very early stages of the disease, especially in pre-motor PD. Thus, there is great interest in finding a biomarker for PD. Among diagnostic biomarkers, the most promising...
Main Authors: | Ewa Papuć, Konrad Rejdak |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2020-07-01
|
Series: | Frontiers in Aging Neuroscience |
Subjects: | |
Online Access: | https://www.frontiersin.org/article/10.3389/fnagi.2020.00156/full |
Similar Items
-
Increased CSF NFL in Non-demented Parkinson’s Disease Subjects Reflects Early White Matter Damage
by: Ewa Papuć, et al.
Published: (2020-05-01) -
Serum and cerebrospinal fluid S100B concentrations in patients with neurocysticercosis
by: J.E. Lima, et al.
Published: (2006-01-01) -
Humoral response against myelin associated glycoprotein reflects oligodendroglial degeneration in Parkinson’s disease
by: Ewa Papuć, et al.
Published: (2016-06-01) -
The level of neuron-specific enolase and S-100 protein in the cerebrospinal fluid of patients with acute bacterial meningitis
by: A. V. Sokhan
Published: (2016-08-01) -
Association of glial and neuronal degeneration markers with Alzheimer’s disease cerebrospinal fluid profile and cognitive functions
by: Unnur D. Teitsdottir, et al.
Published: (2020-08-01)